Canada approves the health effects of shrimp shells
Research on shrimp shells carried out by Nofima more than 10 years ago can now be a commercial success. The Marealis company carried out a large-scale trial production at Nofima’s pilot factory Biotep, with very promising effects. The blood pressure lowering supplement will soon be launched in Canada.
Marealis’ novel shrimp peptide gains EFSA green light
he European Food Safety Authority (EFSA) has approved an application for the novel food status of a shrimp peptide concentrate, meaning that the ingredient can now be utilized in EU supplement applications.
Canada approves shrimp shell-based health supplements for sale
Canadian health authorities have become the first in the world to approve the positive health effects of the peptides in shrimp shells, announced Norwegian research body Nofima.